MetLife MET Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 20.3%-1.6pp | 21.7%+2.5pp | 23.6%+8.2pp | 23.5%+9.4pp | 21.9%+7.4pp | |
| Returns | ||||||
| Return on equity | 53.8%-1.2pp | 56.6%+10.0pp | 59.9%+23.4pp | 60.4%+27.2pp | 54.9%+22.2pp | |
| Return on assets | 2.1%-0.2pp | 2.3%+0.3pp | 2.5%+0.9pp | 2.5%+1.1pp | 2.3%+0.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 2.2×0.0× | 2.2×0.0× | 2.3×+0.1× | 2.2×-0.1× | 2.2×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Valuation | ||||||
| Market capitalization | $206.38B-6.5% | $214.96B-2.1% | $219.64B+4.0% | $223.47B+11.8% | $220.75B+15.2% | |
| Enterprise value | $181.5B-9.0% | $191.67B-4.6% | $198.98B+3.5% | $201.28B+7.3% | $199.4B+8.2% | |
| Price / earnings | 54.9×-3.1× | 54.3×-14.2× | 51.7×-34.6× | 53×-36.3× | 58×-27.0× | |
| Price / sales | 2.8×-0.3× | 2.9×-0.2× | 3×0.0× | 3.1×+0.1× | 3.1×+0.2× | |
| Price / book | 7.3×-0.5× | 7.6×-0.1× | 7.9×+0.6× | 7.9×+0.7× | 7.8×+1.1× | |
| EV / sales | 2.4×-0.4× | 2.6×-0.3× | 2.8×0.0× | 2.8×0.0× | 2.8×0.0× | |
| Earnings yield | 29.4%+1.2pp | 29.8%+5.4pp | 31.1%+11.2pp | 30.5%+11.7pp | 28.2%+7.5pp | |
| Dividend yield | 11.8%+0.6pp | 11.3%0.0pp | 11.1%-0.7pp | 10.9%-1.6pp | 11.1%-2.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do MetLife's ratios come from?
- Every ratio is computed from MetLife's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
